Running a clinical trial for rare diseases is very different from trials in more common conditions. Small patient numbers, limited data, and complicated rules make every part of the process more careful and more creative. Instead of going over the basics, this article focuses on advanced but practical things that experienced sponsors need to think […]
Read More →In clinical research, understanding the distinctions between rare and standard disease trials is crucial for optimizing study design and execution. Rare disease trials focus on conditions that affect a small percentage of the population, while standard disease trials target more prevalent conditions. However, both types of trials are equally important in advancing medical science and […]
Read More →Clinical trials in rare diseases present more significant challenges compared to trials in more common diseases. These challenges arise due to various factors, including trial design, the limited patient population for recruitment, regulatory support, and more. However, implementing a well-defined strategy for clinical development in rare diseases can help overcome these challenges. Such a strategy […]
Read More →